In trading on Wednesday, shares of Synageva BioPharma Corp (GEVA) crossed below their 200 day moving average of $49.95, changing hands as low as $49.43 per share. Synageva BioPharma Corp shares are currently trading off about 4.4% on the day. The chart below shows the one year performance of GEVA shares, versus its 200 day moving average:Looking at the chart above, GEVA's low point in its 52 week range is $34.01 per share, with $58.00 as the 52 week high point — that compares with a last trade of $49.41. According to the ETF Finder at ETF Channel, GEVA makes up 1.23% of the SPDR S&P Biotech ETF ( XBI) which is trading lower by about 1.2% on the day Wednesday.
HOST // Robert Powell
Retirement Planning Event
More from Stocks
Yield-Curve Inversion Isn't Threatening Stocks Yet -- Here's When It Will
Why you shouldn't care about the yield-curve inversion now, but should care about it later.
Boeing Pares Gains as China Regulators Suspend 737 MAX 8 Safety Certification
Boeing shares pared pre-market gains Tuesday as officials in China moved to suspend safety certifications for the 737 MAX 8 and European rival Airbus inked a $34 billion order with Beijing that matches a similar-sized deal made with the world's biggest planemaker during a 2017 visit by President Donald Trump.
'A Billion Pockets': Apple's Installed Base Is the Real Star of Its Service Push
Apple brought out some of Hollywood's heavy hitters to show off its new services offerings, which included Apple TV+, Apple TV Channels, Apple News+ and Apple Card. But for investors, the real draw may be Apple's 1.4 billion installed base.
Apple Resumes Drive to $1 Trillion With Services Move Into 'One Billion Pockets'
Apple shares edged higher in pre-market trading Tuesday after the world's biggest tech company unveiled a raft of new businesses, spanning from online streaming to credit cards, amid it leveraging the loyalty of its 1.4 billion customers as it moves to become less reliant on iPhone sales and focus on subscription and services revenues.